Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Pearls & Oy-sters: Diagnosis of Pediatric Tumefactive Multiple Sclerosis With MRI Biomarkers.
Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety.
Resolution Failure in Multiple Sclerosis: Linking Lipid Mediators to Neuroinflammation and Disease Progression.
Pearls & Oy-sters: DPPX Antibody-Associated Encephalitis in a Patient With Diarrhea, Tremor, Ocular Flutter, and Cognitive-Psychiatric Changes.
Uncommon indications in chronic pain for intrathecal drug delivery systems: a narrative review of the literature.
From MRI activity to treatment escalation in relapsing multiple sclerosis: what can new T2 lesions tell us?
Inflammatory neuropathy in mouse and primate models of colorectal cancer.
Clinical decision-making in older adults with multiple sclerosis: A National Delphi survey of Israeli MS specialists.
Recognition and management of acute relapse of multiple sclerosis, neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.
Intranasal stem cell treatment ameliorates neuroinflammation and myelin aberrations in fetal growth-restricted rat pups.
Autologous haematopoietic stem cell transplantation stabilizes retinal atrophy in multiple sclerosis.
Case Report: Panic attack induced by albendazole in a post-PCI patient.
Minocycline ameliorates CNS autoimmunity through restraint of CD4CD11bc cells.
RhoA in postnatal spinal motoneuron is essential for peripheral myelination.
Zygosity-Dependent Phenotypic Spectrum of -Related Disorders: 10 New Patients and Genotype-Phenotype Correlations Across 48 Kindreds.
IL-34 in neurological homeostasis and its multifaceted roles in central nervous system diseases.
Downregulation of IFNG-AS1 and UCHL1-AS1 in Peripheral Blood Cells of Multiple Sclerosis Patients: IFNG-AS1 as a Candidate Diagnostic Biomarker.
Discriminative accuracy of the 42-point modified Mini-Balance Evaluation Systems Test for identifying Expanded Disability Status Scale-defined disability in relapsing-remitting multiple sclerosis: an exploratory diagnostic accuracy study.
Real-World Outcomes of Ocrelizumab and Ofatumumab Treatment in Pediatric-Onset Multiple Sclerosis.
Integrative Perspectives on COX-2 Signaling and Selective Inhibitors in Central Nervous System Disorders: A Narrative Review.
Micheliolide and ACT001 as Covalent Modulators of Inflammation-Redox-Metabolism Networks in CNS Disorders: An Evidence-Stratified Review of Mechanisms and Translational Challenges.
Lipid metabolism dysregulation in late-life depression: peripheral metabolic disturbance, central lipid alterations, and dietary modulation.
Neurological and Neuropsychiatric Manifestations of Pediatric Inflammatory Multisystem Syndrome (PIMS/MIS-C): A Narrative Review.
Neuregulin-1 as a Context-Dependent Regulator of Neuroinflammation and Neural Repair: Mechanisms, Disease Relevance, and Therapeutic Challenges.
IgA Deficiency Exacerbates an Animal Model of Multiple Sclerosis Induced with Theiler's Virus.

Pages